Conference call regarding Elekta's Q3 report for 2017/18
STOCKHOLM, February 16, 2018 – Elekta (EKTA-B.ST) will publish its Q3 report for 2017/18 on March 2, as per:
- The report will be published at 07:30 CET.
- Elekta will host a telephone conference starting at 10:00 CET with Richard Hausmann, President and CEO, and Gustaf Salford, CFO.
To take part in the conference call, please dial in about five minutes in advance.
- UK dial-in number: +44 (0) 203 008 9808
- US dial-in number: +1 855 753 2237
- Swedish dial-in number: +46 (0) 8 566 426 91
The telephone conference will also be broadcasted live online, through the following link (however, in order to ask questions it is necessary to call in): http://event.on24.com/wcc/r/1610945-1/DED93131C299D012C6AE58D8B0CA96B6?partnerref=rss-events
# # #
About Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm www.elekta.com
Downloads
For further information, please contact
Johan Andersson, Director Investor Relations, Elekta AB.
Tel: +46 702 100 451,
E-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
Tobias Bülow, Director Financial Communications, Elekta AB
Tel: +46 722 215 017,
E-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time